CoChat

Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

Background: According to the literature, pigmentary disorders have a significantly negative impact on a person’s health-related quality of life. Moreover, among pigmentary disorders, incidence of melasma ranks high. The Melasma Area and Severity Index (MASI) is the scale that is generally used to evaluate a melasma-affected area and its severity. However, the relationship between the MASI and Melasma Quality of Life (MELASQoL) scores, as well as the impact of melasma on patients’ quality of life, remain unclear. Objectives: To explore the influence of melasma on patients’ lives, analyze the relationship between the MASI and MELASQoL scores, and identify the factors that may be influencing the quality of life of patients with melasma. Methods: Two reviewers independently searched four databases (PubMed, Embase, the Cochrane Library, and Web of Science) for literature on quality of life of patients with melasma. In addition to an epidemiological study, a cross-sectional study, and validation studies, gray literature was also included. StataSE version 16 software was used for the meta-analysis. The score of each item on the MELASQoL scale was determined using a random-effects model. Results: Fourteen studies with a total of 1398 melasma patients were included in the systematic review, four of which were eligible for meta-analysis. The relationship between the MELASQoL and MASI scores was found to be mixed. Five studies concluded that the MASI and MELASQoL scores were statistically correlated, while seven studies found no statistical correlation between the two. It is obvious that melasma causes emotional distress and has a negative impact on patients’ social lives. Patients were most bothered by the appearance of their skin condition. However, the MELASQoL score had no definite correlation with patient characteristics such as age, education levels, and history. Conclusion: Melasma has a significant negative impact on patients’ quality of life. Thus, evaluating the quality of life of patients with melasma should not be ignored. Additionally, utilization of the MELASQoL scale should be considered in the care plan. Further studies with larger sample sizes are needed to confirm the relationship between melasma and quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0262833

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA flow diagram.
Fig 1 PRISMA flow diagram.CC BY · PubMed Central
Fig 2 Study quality assessment of the included studies based on the JBI critical appraisal checklist.
Fig 2 Study quality assessment of the included studies based on the JBI critical appraisal checklist.CC BY · PubMed Central
Fig 3 Meta-analysis of the studies that reported on the individual domains of the MELASQoL scale.
Fig 3 Meta-analysis of the studies that reported on the individual domains of the MELASQoL scale.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. MP Fleck, 2000, Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref, Revista de saude publica, 34, 178
  2. EJ Park, 2013, Usefulness of Melasma Quality of Life Scale (MELASQOL) when evaluating the quality of life in Korean melasma patients, Korean Journal of Dermatology, 51, 422

Cited by

See all 105

Metadata

Authors
Zhu, Y., Zeng, X., Ying, J., Cai, Y., Qiu, Y., & Xiang, W.
Affiliations
  • Zhejiang Chinese Medical University (CN)
  • Third People's Hospital of Hangzhou (CN)
Corresponding author
Xiang, Wenzhong
Venue
PLOS ONE
Published
2022-01-27
Volume
17
Issue
1
Pages
e0262833
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4210262340
Cited by
66
References
39
Citations by year
2026: 21 · 2025: 17 · 2024: 14 · 2023: 13 · 2022: 1
FWCI
2.00
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Zhejiang Medical and Health Science and Technology Program, China (2020364003)
  • National Natural Science Foundation of China (81872517)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
Keywords
melasma, health-related quality of life, MELASQoL, Melasma Area and Severity Index, skin pigmentation disorders, emotional distress, social impact, patient-reported outcomes
MeSH terms
Humans, Melanosis, Quality of Life, Stress, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0262833
The paper
Zhu, Y., Zeng, X., Ying, J., Cai, Y., Qiu, Y., & Xiang, W. (2022). Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0262833

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.